PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.\', \'COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia.\', \'Louisiana Public Health Institute, New Orleans, Louisiana.\', \'Applied Clinical Research Center, Department of Pediatrics, Children\'s Hospital of Philadelphia, Philadelphia, Pennsylvania.\', \'Department of Population and Data Sciences, Department of Immunology, University of Texas Southwestern Medical Center, Dallas.\', \'Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts.\', \'Fenway Health, Boston, Massachusetts.\', \'OCHIN Inc, Portland, Oregon.\', \'Department of Pediatrics, University of Florida College of Medicine, Gainesville.\', \'Health Research & Solutions, Cook County Health, Chicago, Illinois.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamanetworkopen.2021.47053
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 35119459
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all